Simplify Exchange Traded Funds Simplify Enhanced Income ETF (ARCA: HIGH)

Latest News for Simplify Exchange Traded Funds Simplify Enhanced Income ETF (ARCA:HIGH)

Simplify Exchange Traded Funds Simplify Enhanced Income ETF

Highstreet - United States Dollar

HIGH ARCTIC ENGY SVCS by High Arctic Energy Services., Inc.

High Arctic Energy Services Inc

HIGH COUNTRY BANCORP INC by High Country Bancorp, Inc.

High Country Bancorp Inc

High Income Securities Fund

HIGH LINER FOODS INC by High Liner Foods Inc.

High Liner Foods Inc

HIGH NORTH RES LTD by High North Resources Ltd

High North Resources Ltd

HIGH PERFORM BEV CO by High Performance Beverages Co

High Performance Beverages Co

High Performance Blockchain

High Roller Technologies, Inc

HIGH SIERRA TECH by High Sierra Technologies Inc.

High Sierra Technologies Inc

High Tide Inc

HIGH WIRE NETWORKS INC. by High Wire Networks Inc.

High Wire Networks Inc

HighCape Capital Acquisition Corp. II

HIGHCOM GLOBAL SEC by HighCom Global Security, Inc.

HighCom Global Security Inc

HighCom Ltd

HIGHGOLD MNG INC NEW by HighGold Mining Inc.

HighGold Mining Inc

HighGold Mining Inc Ordinary Shares - Class A

HighPeak Energy Inc

HIGHTIDE THERAPEUTICS INC by HIGHTIDE THERAPEUTICS INC

HighTide Therapeutics Inc

HIGHBANK RES LTD by Highbank Resources Ltd.

Highbank Resources Ltd

Highcliff Metals Corp

HIGHCLIFF METALS CORP by HIGHCLIFF METALS CORP.

Highest Performances Holdings Inc. - American Depository Shares

Highest Performances Holdings Inc

HIGHLAND COPPER CO INC by Highland Copper Company Inc.

Highland Copper Co Inc

Highland Global Allocation Fund Common Stock

Highland Global Allocation Fund

Highland Opportunities and Income Fund 5.375% Series A Cumulative Preferred Shares

Highland Opportunities and Income Fund

Highland Opportunities and Income Fund Common Shares of Beneficial Interest

HIGHLAND SURPRISE CON MNG by Highland Surprise Consolidated Mining Co.

Highland Surprise Consolidated Mining Co

HIGHLANDS BANKSHARES INC by Highlands Bankshares, Inc.

Highlands Bankshares Inc (WV)

HIGHLANDS REIT INC by Highlands REIT Inc.

Highlands REIT Inc

Highwater Ethanol LLC

HIGHWAY 50 GOLD CORP by Highway 50 Gold Corp.

Highway 50 Gold Corp

Highway Holdings Ltd

Highwoods Properties Inc

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>Moderna</strong>.</p>
<p>Looking at options history for Moderna (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MRNA#NASDAQ">MRNA</a>) we detected 17 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 41% of the investors opened trades with bullish expectations and 41% with bearish.</p>
<p>From the overall spotted trades, 8 are puts, for a total amount of $635,317 and 9, calls, for a total amount of $600,368.</p>
<h3>What's The Price Target?</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $100.0 and $175.0 for Moderna, spanning the last three months.</p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>Assessing the volume and open interest is a strategic step in options trading. These metrics shed light on the liquidity and investor interest in Moderna's options at specified strike prices. The forthcoming data visualizes the fluctuation in volume and open interest for both calls and puts, linked to Moderna's substantial trades, within a strike price spectrum from $100.0 to $175.0 over the preceding 30 days.</p>
<h3>Moderna Call and Put Volume: 30-Day Overview</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715797923_0.png" alt="Options Call Chart" /></p>
<h3>Biggest Options Spotted:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>NEUTRAL</td>
<td>06/28/24</td>
<td>$7.05</td>
<td>$7.0</td>
<td>$7.0</td>
<td>$125.00</td>
<td>$363.3K</td>
<td>0</td>
<td style="text-align: right;">519</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>05/17/24</td>
<td>$24.45</td>
<td>$22.75</td>
<td>$23.6</td>
<td>$104.00</td>
<td>$136.8K</td>
<td>159</td>
<td style="text-align: right;">79</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$4.65</td>
<td>$4.6</td>
<td>$4.6</td>
<td>$145.00</td>
<td>$98.4K</td>
<td>11.4K</td>
<td style="text-align: right;">293</td>
</tr>
<tr>
<td>MRNA</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/28/24</td>
<td>$8.95</td>
<td>$8.65</td>
<td>$8.91</td>
<td>$128.00</td>
<td>$89.2K</td>
<td>0</td>
<td style="text-align: right;">100</td>
</tr>
<tr>
<td>MRNA</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>06/20/25</td>
<td>$15.35</td>
<td>$14.8</td>
<td>$14.8</td>
<td>$175.00</td>
<td>$81.4K</td>
<td>0</td>
<td style="text-align: right;">61</td>
</tr>
</tbody>
</table>
</p>
<h3>About Moderna</h3>
<p>Moderna is a commercial-stage biotech that was founded in 2010 and had its initial public offering in December 2018. The firm's mRNA technology was rapidly validated with its COVID-19 vaccine, which was authorized in the United States in December 2020. Moderna had 39 mRNA development candidates in clinical trials as of mid-2023. Programs span a wide range of therapeutic areas, including infectious disease, oncology, cardiovascular disease, and rare genetic diseases.</p>
<p>After a thorough review of the options trading surrounding Moderna, we move to examine the company in more detail. This includes an assessment of its current market status and performance.</p>
<h3>Present Market Standing of Moderna</h3>
<ul>
<li>Currently trading with a volume of 1,671,221, the MRNA's price is up by 0.02%, now at $128.34. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 78 days.</li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Moderna options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


Options

Markets

MRNA

Smart Money Is Betting Big In MRNA Options

<p>Financial giants have made a conspicuous bullish move on Celsius Holdings. Our analysis of options history for Celsius Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CELH#NASDAQ">CELH</a>) revealed 15 unusual trades.</p>
<p>Delving into the details, we found 40% of traders were bullish, while 40% showed bearish tendencies. Out of all the trades we spotted, 3 were puts, with a value of $168,026, and 12 were calls, valued at $552,956.</p>
<h3>Predicted Price Range</h3>
<p>Taking into account the Volume and Open Interest on these contracts, it appears that whales have been targeting a price range from $60.0 to $105.0 for Celsius Holdings over the last 3 months. </p>
<h3>Analyzing Volume &amp; Open Interest</h3>
<p>In terms of liquidity and interest, the mean open interest for Celsius Holdings options trades today is 919.46 with a total volume of 883.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for Celsius Holdings's big money trades within a strike price range of $60.0 to $105.0 over the last 30 days.</p>
<h3>Celsius Holdings Option Activity Analysis: Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715797918_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>01/17/25</td>
<td>$17.7</td>
<td>$17.65</td>
<td>$17.65</td>
<td>$96.67</td>
<td>$88.2K</td>
<td>111</td>
<td style="text-align: right;">50</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>07/19/24</td>
<td>$13.6</td>
<td>$13.45</td>
<td>$13.55</td>
<td>$85.00</td>
<td>$67.7K</td>
<td>2.3K</td>
<td style="text-align: right;">88</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>07/19/24</td>
<td>$13.6</td>
<td>$13.4</td>
<td>$13.46</td>
<td>$85.00</td>
<td>$67.3K</td>
<td>2.3K</td>
<td style="text-align: right;">140</td>
</tr>
<tr>
<td>CELH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BULLISH</td>
<td>01/16/26</td>
<td>$40.5</td>
<td>$40.25</td>
<td>$40.5</td>
<td>$70.00</td>
<td>$56.7K</td>
<td>569</td>
<td style="text-align: right;">24</td>
</tr>
<tr>
<td>CELH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BEARISH</td>
<td>06/21/24</td>
<td>$3.85</td>
<td>$3.75</td>
<td>$3.84</td>
<td>$90.00</td>
<td>$53.7K</td>
<td>399</td>
<td style="text-align: right;">176</td>
</tr>
</tbody>
</table>
</p>
<h3>About Celsius Holdings</h3>
<p>Celsius Holdings plays in the energy drink subsegment of the global nonalcoholic beverage market, with 96% of revenue concentrated in North America. Celsius' products contain natural ingredients and a metabolism-enhancing formulation, appealing to fitness and active lifestyle enthusiasts. The firm's portfolio includes its namesake Celsius Originals beverages (including those that are naturally caffeinated with stevia), Celsius Essentials line (containing aminos), and Celsius On-the-Go powder packets. Celsius focuses its time on branding and innovation, while it utilizes third parties for the manufacturing, packaging, and distribution of its products. In 2022, Celsius forged a 20-year distribution agreement with PepsiCo, which holds an 8.5% stake in the business.</p>
<p>Having examined the options trading patterns of Celsius Holdings, our attention now turns directly to the company. This shift allows us to delve into its present market position and performance</p>
<h3>Celsius Holdings's Current Market Status</h3>
<ul>
<li>Currently trading with a volume of 2,263,701, the CELH's price is up by 2.07%, now at $93.44. </li>
<li>RSI readings suggest the stock is currently may be overbought.</li>
<li>Anticipated earnings release is in 83 days.</li>
</ul>
<h3>Professional Analyst Ratings for Celsius Holdings</h3>
<p>A total of 4 professional analysts have given their take on this stock in the last 30 days, setting an average price target of $90.5.</p>
<ul>
<li>An analyst from Stifel persists with their Buy rating on Celsius Holdings, maintaining a target price of $85. </li>
<li>An analyst from Wedbush has decided to maintain their Outperform rating on Celsius Holdings, which currently sits at a price target of $85. </li>
<li>Reflecting concerns, an analyst from Wedbush lowers its rating to Outperform with a new price target of $100.</li>
<li>Consistent in their evaluation, an analyst from UBS keeps a Buy rating on Celsius Holdings with a target price of $92. </li>
</ul>
<p>Options trading presents higher risks and potential rewards. Astute traders manage these risks by continually educating themselves, adapting their strategies, monitoring multiple indicators, and keeping a close eye on market movements. Stay informed about the latest Celsius Holdings options trades with real-time alerts from <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a>.</p>


CELH

Unpacking the Latest Options Trading Trends in Celsius Holdings

<p>Whales with a lot of money to spend have taken a noticeably bullish stance on <strong>UiPath</strong>.</p>
<p>Looking at options history for UiPath (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PATH#NYSE">PATH</a>) we detected 8 trades.</p>
<p>If we consider the specifics of each trade, it is accurate to state that 75% of the investors opened trades with bullish expectations and 25% with bearish.</p>
<p>From the overall spotted trades, 2 are puts, for a total amount of $181,759 and 6, calls, for a total amount of $191,900.</p>
<h3>Expected Price Movements</h3>
<p>After evaluating the trading volumes and Open Interest, it's evident that the major market movers are focusing on a price band between $12.5 and $30.0 for UiPath, spanning the last three months.</p>
<h3>Volume &amp; Open Interest Development</h3>
<p>In terms of liquidity and interest, the mean open interest for UiPath options trades today is 1167.0 with a total volume of 787.00.</p>
<p>In the following chart, we are able to follow the development of volume and open interest of call and put options for UiPath's big money trades within a strike price range of $12.5 to $30.0 over the last 30 days.</p>
<h3>UiPath Option Volume And Open Interest Over Last 30 Days</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715797913_0.png" alt="Options Call Chart" /></p>
<h3>Significant Options Trades Detected:</h3>
<p>
<table>
<thead>
<tr>
<th><strong>Symbol</strong></th>
<th><strong>PUT/CALL</strong></th>
<th><strong>Trade Type</strong></th>
<th><strong>Sentiment</strong></th>
<th><strong>Exp. Date</strong></th>
<th><strong>Ask</strong></th>
<th><strong>Bid</strong></th>
<th><strong>Price</strong></th>
<th><strong>Strike Price</strong></th>
<th><strong>Total Trade Price</strong></th>
<th><strong>Open Interest</strong></th>
<th style="text-align: right;"><strong>Volume</strong></th>
</tr>
</thead>
<tbody>
<tr>
<td>PATH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$8.95</td>
<td>$8.85</td>
<td>$8.85</td>
<td>$29.00</td>
<td>$101.8K</td>
<td>245</td>
<td style="text-align: right;">116</td>
</tr>
<tr>
<td>PATH</td>
<td>PUT</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>11/15/24</td>
<td>$9.85</td>
<td>$9.75</td>
<td>$9.75</td>
<td>$30.00</td>
<td>$79.9K</td>
<td>10</td>
<td style="text-align: right;">83</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>05/17/24</td>
<td>$3.55</td>
<td>$3.45</td>
<td>$3.5</td>
<td>$17.00</td>
<td>$51.1K</td>
<td>477</td>
<td style="text-align: right;">147</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>SWEEP</td>
<td>BULLISH</td>
<td>08/16/24</td>
<td>$3.15</td>
<td>$3.05</td>
<td>$3.15</td>
<td>$19.00</td>
<td>$31.5K</td>
<td>2.1K</td>
<td style="text-align: right;">112</td>
</tr>
<tr>
<td>PATH</td>
<td>CALL</td>
<td>TRADE</td>
<td>BEARISH</td>
<td>01/16/26</td>
<td>$3.6</td>
<td>$3.05</td>
<td>$3.05</td>
<td>$30.00</td>
<td>$30.5K</td>
<td>1.5K</td>
<td style="text-align: right;">1</td>
</tr>
</tbody>
</table>
</p>
<h3>About UiPath</h3>
<p>UiPath Inc creates an end-to-end platform that provides automation with user emulation at its core. Its platform is built to be used by employees throughout a company and to address a wide variety of use cases, from simple tasks to long-running, complex business processes. It generates revenue from the sale of licenses for its proprietary software, maintenance and support, the right to access certain software products it hosts (i.e., SaaS) and professional services. It generates a majority of its revenues from the Americas followed by Europe, Middle East, and Africa and Asia-Pacific.</p>
<h3>Where Is UiPath Standing Right Now?</h3>
<ul>
<li>With a volume of 4,229,238, the price of PATH is up 2.4% at $20.68. </li>
<li>RSI indicators hint that the underlying stock may be approaching overbought.</li>
<li>Next earnings are expected to be released in 14 days.</li>
</ul>
<p>Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for UiPath with <a href="https://benzinga.grsm.io/register174">Benzinga Pro</a> for real-time alerts.</p>


PATH

UiPath Options Trading: A Deep Dive into Market Sentiment

Hedge Funds

General

13F Shows Tiger Global Management Increased Stake in Sea Ltd from 14.3M Shares to 15M Shares

<p>Spotify Technology (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPOT#NYSE">SPOT</a>) has outperformed the market over the past 5 years by 4.75% on an annualized basis producing an average annual return of 17.81%. Currently, Spotify Technology has a market capitalization of $59.51 billion. </p>
<p><strong>Buying $100 In SPOT:</strong> If an investor had bought $100 of SPOT stock 5 years ago, it would be worth <strong>$228.22</strong> today based on a price of $298.97 for SPOT at the time of writing.</p>
<h3>Spotify Technology's Performance Over Last 5 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715797818_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


News

Trading Ideas

SPOT

$100 Invested In This Stock 5 Years Ago Would Be Worth $200 Today

<p>MercadoLibre (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MELI#NASDAQ">MELI</a>) has outperformed the market over the past 10 years by 24.92% on an annualized basis producing an average annual return of 35.86%. Currently, MercadoLibre has a market capitalization of $85.37 billion. </p>
<p><strong>Buying $100 In MELI:</strong> If an investor had bought $100 of MELI stock 10 years ago, it would be worth <strong>$2,052.27</strong> today based on a price of $1683.91 for MELI at the time of writing.</p>
<h3>MercadoLibre's Performance Over Last 10 Years</h3>
<p><img src="https://www.benzinga.com/files/images/story/2024/1715797813_0.png" alt="comp_fig" /></p>
<p>Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.</p>
<p><em>This article was generated by Benzinga's automated content engine and reviewed by an editor.</em></p>


MELI

$100 Invested In This Stock 10 Years Ago Would Be Worth $2,100 Today

<p>Oceanwide Plaza started as a set of ultraluxury mixed-use skyscrapers that were intended to serve as bookends to downtown Los Angeles' rebranding as a modernized urban paradise. Instead, a developer default resulted in a national scandal where the unfinished towers became so popular with graffiti artists that Oceanwide was unofficially known as "the Graffiti Towers." The property is finally being put up for sale.</p>
<p>On paper, Oceanwide Plaza seemed like the perfect match for downtown Los Angeles. Situated adjacent to the Crypto.com Arena (home of the Los Angeles Lakers and the Los Angeles Clippers) and LA Live entertainment district, Oceanwide Plaza's combination of luxury condominiums, retail suites, hotels and apartments was a perfect fit. The original developer, China-based Oceanwide Holdings, began developing this masterpiece in 2014, a time when interest rates were low, and China's economy was booming.</p>
<p>Unfortunately for Oceanwide Holdings, things changed by 2019, at a time when the Oceanwide Plaza was tantalizingly close to completion. The exoskeleton of the towers, with its stairs, windows, and concrete floors was already done when the Chinese government decided to restrict funds for developments being done outside the country. That's about the time contractors ceased to be paid.</p>
<p>&nbsp;<strong>Don't Miss:</strong></p>
<ul>
<li>Warren Buffett once said, "If you don't find a way to make money while you sleep, you will work until you die." <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">Here's how you can collect passive rental income without being a landlord</a>.</li>
<li>Elon Musk and Jeff Bezos are bullish on one city that could dethrone New York and become the new financial capital of the US. <a href="https://www.benzinga.com/money/miami-take-new-yorks-place-financial-capital">Investing in its booming real estate market has never been more accessible</a>. </li>
</ul>
<p>One by one, the contractors who weren't getting paid stopped working. Then the COVID crisis hit in 2020, and construction on Oceanwide Plaza ground to a halt. By the time things began to return to "normal" again in 2021 and 2022, Oceanwide Holdings was in desperate financial straits, with <a href="https://www.benzinga.com/economics/macro-economic-events/24/05/38759943/atlanta-fed-chief-hints-at-potential-interest-rate-cut-this-year-amid-economic-un">interest rates</a> already on the rise. Unable to refinance, and already drowning in debt, Oceanwide Holdings simply abandoned the project.</p>
<p>That's when it became famous for all the wrong reasons. It wasn't long before squatters, graffiti artists, and BASE jumpers realized there was little more than a chain-link fence and a part-time guard securing Oceanwide Plaza. Soon, the towers were covered from head to toe in graffiti and BASE jumpers were filming live YouTube videos of their exploits. An exasperated LA City Council was forced to set aside millions of dollars to help secure the premises.</p>
<p><strong>Trending:</strong></p>
<ul>
<li>Want to Create a Passive Income Stream? <a href="https://www.benzinga.com/real-estate/23/05/32554601/want-to-grow-your-wealth-passively-these-high-yield-real-estate-notes-might-be-your-holy-grail">These High-Yield Real Estate Notes Might Be Your Holy Grail</a></li>
</ul>
<p>By the time Oceanwide Plaza's General Contractor Lendlease filed an involuntary Chapter 11 proceeding for $400 million in February of 2024, Oceanwide Plaza had become known nationwide as "The Graffiti Towers." With that in mind, the news of the development being listed for sale by Coliers and Hilco real estate brokerage came as a great relief to both city leaders and owners of nearby properties.</p>
<p>Ironically, the fact that Oceanwide Plaza is partially completed might make it an attractive investment opportunity for the right buyer. It still has an outstanding location and about 2/3 of the construction is already done. Coliers and Hilco estimated Oceanwide Plaza's "as-is market value" at roughly $450 million and estimated that it will require an additional $850 million to complete. Although those numbers sound astronomical, Coliers and Hilco believe Oceanwide Plaza presents a great opportunity for the right investor.</p>
<p>In an interview with the LA Times, Broker Mark Tarczyznski speculates that the most likely purchasers are institutional investors such as <a href="https://www.benzinga.com/real-estate/reit/24/05/38741285/7-reits-receive-analyst-upgrades-in-the-first-week-of-may">REIT</a>s or sovereign wealth funds. He is bullish on the building's potential but recognizes there is a limited number of people who can afford such an undertaking. "I think there&#8217;s a broad range of buyers," he said, "but the pool of buyers is small because of the size of the project."</p>
<p><strong>Read Next:</strong></p>
<ul>
<li>Passive income investments are one of the most trusted methods for riding out a recession, so it's no surprise that people are turning to this <a href="https://www.benzinga.com/money/bezos-landlord-100-dollars">Jeff Bezos-backed startup to generate monthly rental income without having to purchase their own property</a>.</li>
<li>Commercial real estate has historically outperformed the stock market, but few investors have the capital or resources needed to invest in this asset class. This platform <a href="https://www.benzinga.com/money/marcus-millichap-backed-platform-makes-it-easy-to-invest-in-real-estate">allows individuals to invest in commercial real estate with as little as $5,000. </a></li>
</ul>


Real Estate

Downtown Los Angeles' Infamous Graffiti Towers Put Up For Sale

CPAY

13F Shows Tiger Global Management Took 1.33M Share Stake In Corpay

AMZN

13F Shows Tiger Global Management Increased Stake in Amazon Com Inc from 4.88M To 6.3M

<p><a href="https://register.epo.org/application?number=EP21186345" title="https://register.epo.org/application?number=EP21186345">https://register.epo.org/application?number=EP21186345</a></p>


CELU

Celularity Granted European Patent EP3957315 For Treatment Of Diabetic Peripheral Neuropathy Using Placental Cells

<p>During the last financial quarter, <strong>Sony Group Corp</strong>. (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SONY#NYSE">SONY</a>) significantly outperformed <strong>Microsoft Corp.</strong> (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MSFT#NASDAQ">MSFT</a>) in console shipments, with the <strong>PlayStation 5 </strong>(PS5) shipping nearly five times more units than the<a href="https://www.benzinga.com/general/gaming/24/05/38767940/xbox-president-sarah-bond-hints-at-call-of-duty-2024s-day-one-inclusion-on-game-pass"> <strong>Xbox Series X and S.</strong> </a></p>
<p><a href="https://www.ign.com/articles/ps5-shipped-almost-5x-more-than-xbox-series-x-and-s-during-last-quarter-analyst-reports">According</a> to IGN, Sony announced this week that it shipped 4.5 million PS5 units during the three-month period ending March 31, 2024, a decrease from the 6.3 million shipped in the same period the previous year.</p>
<p><em>See Also: <a href="https://www.benzinga.com/general/gaming/24/03/37945607/xbox-in-trouble-as-a-hardware-manufacturer-faces-sales-decline-in-europe-report">Xbox &#8216;In Trouble As A Hardware Manufacturer,&#8217; Faces Sales Decline In Europe: Report</a></em></p>
<p>In contrast, Microsoft <a href="https://www.benzinga.com/news/earnings/24/04/38466580/microsoft-thanks-call-of-duty-candy-crush-for-sizzling-q3-gaming-results">reported a 31% decline in Xbox hardware revenue</a> and, while it does not disclose specific sales figures, estimates suggest it shipped around 900,000 Xbox Series X and S consoles.</p>
<p><strong>Daniel Ahmad</strong>, director of research and insights at Niko Partners, highlighted this disparity, noting that the PS5 outsold the Xbox Series X and S by a ratio of 5:1 during the quarter.</p>
<p>Historically, the gap between the two consoles was closer to 2:1, with lifetime sales of Xbox Series X and S potentially around 29 million units compared to the PS5&#8217;s 59.3 million units. This widening gap indicates a growing lead for Sony.</p>
<p>Moreover, Ahmad noted on X (formerly known as Twitter): &#8220;The PlayStation 5 has sold 59.2 million units as of March 31, 2024. This is slightly behind the PS4 in the same time frame (60 million). They do not expect the PS5 to surpass the PS4 in the next year.&#8221;</p>
<p>&#8220;In other words, while console hardware sales are healthy, Sony is unable to sell more than the prior gen,&#8221; the analyst added. </p>
<p><figure class="wp-block-embed is-type-rich is-provider-twitter wp-block-embed-twitter"><br />
<div class="wp-block-embed__wrapper">
<blockquote class="twitter-tweet" data-width="500" data-dnt="true"><p lang="en" dir="ltr">4. The PlayStation 5 has sold in 59.2 million units as of March 31, 2024. <br /><br />This is slightly behind the PS4 in the same time frame (60 million). They do not expect the PS5 to surpass the PS4 in the next year. <br /><br />In other words, while console hardware sales are healthy, Sony is… <a href="https://t.co/ExaMQZKQfn">pic.twitter.com/ExaMQZKQfn</a></p>
<p>&mdash; Daniel Ahmad (@ZhugeEX) <a href="https://twitter.com/ZhugeEX/status/1790464368494191043?ref_src=twsrc%5Etfw">May 14, 2024</a></p></blockquote>
<script async src="https://platform.twitter.com/widgets.js" charset="utf-8"></script></div>
<p></p></figure></p>
<p>The declining sales for Xbox hardware are not entirely unexpected, given Microsoft&#8217;s strategic pivot away from prioritizing console sales. </p>
<p>Microsoft has openly acknowledged losing the console war to Sony and is increasingly focusing on software and services, even selling Xbox games on rival platforms like the PS5. </p>
<p>Microsoft&#8217;s gaming business also faced internal challenges, including significant layoffs and the <a href="https://www.benzinga.com/general/gaming/24/05/38678051/microsofts-xbox-closes-4-video-game-studios-in-bethesda-restructure">closure of studios such as Arkane Austin and Tango Gameworks. </a>These measures come in the wake of the $69 billion acquisition of Activision Blizzard, which has placed additional financial pressure on the company.</p>
<p>Meanwhile, Sony appeared to be gearing up for the next phase of its console lifecycle, with plans for a PS5 Pro model and the anticipated release of major titles like Grand Theft Auto 6.</p>
<p><em>Read Next: <a href="https://www.benzinga.com/general/gaming/24/04/38255686/sonys-ps5-pro-release-reports-say-developers-are-getting-ready-for-new-console">Sony&#8217;s PS5 Pro Release: Reports Say Developers Are Getting Ready For New Console</a></em></p>
<p><em>Photo: Shutterstock.</em></p>


Gaming

MSFT

Sony Group Corporation American Depositary Shares

SONY

Sony Ships 4.5M PS5 Units, Outsells Xbox By 5:1 Ratio

Government

Regulations

Politics

JBLU

SAVE

ULCC

U.S. House Approves Sweeping Aviation Safety, Consumer Reform Bill Sending To Biden

GOOG

GOOGL

13F Shows Tiger Global Management Increased Stake In Alphabet From 4.06M To 10.308M Shares

<p>Truist Securities  analyst David Macdonald   maintains Pediatrix Medical Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MD#NYSE">MD</a>) with a Hold and maintains $10 price target.</p>


Price Target

Analyst Ratings

Truist Securities Maintains Hold on Pediatrix Medical Group, Maintains $10 Price Target

<p>Truist Securities  analyst David Macdonald   maintains PACS Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PACS#NYSE">PACS</a>) with a Buy and maintains $32 price target.</p>


PACS

Truist Securities Maintains Buy on PACS Group, Maintains $32 Price Target

<p>Truist Securities  analyst Robyn Karnauskas   maintains Curis (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CRIS#NASDAQ">CRIS</a>) with a Buy and maintains $26 price target.</p>


CRIS

Truist Securities Maintains Buy on Curis, Maintains $26 Price Target

<p>Truist Securities  analyst Joon Lee   maintains Adverum Biotechnologies (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ADVM#NASDAQ">ADVM</a>) with a Buy and maintains $60 price target.</p>


ADVM

Truist Securities Maintains Buy on Adverum Biotechnologies, Maintains $60 Price Target

<p>Truist Securities  analyst David Macdonald   maintains AdaptHealth (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AHCO#NASDAQ">AHCO</a>) with a Buy and maintains $13 price target.</p>


AHCO

Truist Securities Maintains Buy on AdaptHealth, Maintains $13 Price Target

<p>Truist Securities  analyst Jamie Cook   maintains Parker Hannifin (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PH#NYSE">PH</a>) with a Buy and maintains $611 price target.</p>


Truist Securities Maintains Buy on Parker Hannifin, Maintains $611 Price Target

<p>Truist Securities  analyst Jordan Levy   maintains NEXTracker (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/NXT#NASDAQ">NXT</a>) with a Buy and maintains $70 price target.</p>
